| IVD Market in BRIC Countries | | | | • Each report is not only a representation of facts |
| The IVD markets of BRIC economies offer immense | | | | but a discussion of the markets we study. This we |
| growth opportunities due to the increasing healthcare | | | | believe gives the reader on-ground information about |
| budgets in these nations, along with the increasing | | | | the markets within diverse geographies. |
| number of private corporate hospitals, and the rising | | | | • The markets are studied through research |
| income levels backed by a huge, untapped population | | | | interviews conducted with industry participants across |
| bases. Despite regulatory hurdles and other restraints | | | | the respective geographies. The studyincludes |
| such as low consumer awareness and the absence | | | | analytics over the data received for faster decision |
| of regulations concerning patient safety, the BRIC | | | | making. |
| IVD market is expected to grow from $2.9 billion in | | | | • We provide 10% customization. Normally it is |
| 2009 to $7.2 billion-$7.5 billion in 2014 at a CAGR of | | | | seen that clients do not find specific market |
| ~19%-20% from 2009 to 2014. In comparison, the | | | | intelligence that they are looking for. Our |
| growth rate of the global IVD market is pegged at | | | | customization will ensure that you necessarily get the |
| only ~5%-6% in the next five years. Our research | | | | market intelligence you are looking for and we get a |
| indicates that China is expected to command the | | | | loyal customer. |
| largest IVD market among all BRIC economies. ( ) | | | | Key questions answered |
| Scope of the Report | | | | • Which are the high-growth segments/cash cows |
| This report categorizes the BRIC IVD market on the | | | | and how is the market segmented in terms of |
| basis of: | | | | applications, products, services, ingredients, |
| Geography: Brazil, Russia, India and China | | | | technologies, and stakeholders? |
| Diagnostic Services: Hematology, immunology, | | | | • What are market estimates and forecasts; |
| microbiology, molecular diagnostics, urine analysis, etc. | | | | which markets are doing well and which are not? |
| Each section will provide market data, market drivers, | | | | • Where are the gaps and opportunities; what is |
| trends and opportunities, key players, and | | | | driving the market? |
| competitive outlook. This report will also provide | | | | • Which are the key playing fields? Which are the |
| more than 50 market tables for various geographic | | | | winning edge imperatives? |
| regions covering the sub-segments and | | | | • How is the competitive outlook; who are the |
| micro-markets. In addition, the report also provides | | | | main players in each of the segments; what are the |
| 20 company profiles for each of its sub-segments. | | | | key selling products; what are their strategic |
| What makes our reports unique? | | | | directives, operational strengths and product |
| • We provide accurate business intelligence within | | | | pipelines? Who is doing what? |
| the markets we study. | | | | |